Hangzhou, China

Wenteng Chen

USPTO Granted Patents = 2 

Average Co-Inventor Count = 8.5

ph-index = 1


Company Filing History:


Years Active: 2016-2025

Loading Chart...
2 patents (USPTO):

Title: The Innovative Contributions of Wenteng Chen

Introduction

Wenteng Chen, a notable inventor based in Hangzhou, China, has made significant strides in the field of pharmaceutical innovations. With a total of two patents to his name, he has developed compounds that hold promise in treating serious diseases such as Parkinson's disease. His work showcases the impact that dedicated research and development can have on healthcare.

Latest Patents

Chen's latest patents include the formulation and synthesis of 3,4-dihydroxy-n-(1'-benzyl-2′-hydroxyethyl)-2-methylpyridine chloride. This innovative compound is synthesized through a one-step reaction and includes pharmaceutically acceptable salts. Remarkably, it has demonstrated good antiparkinsonian activity in animal tests, presenting itself as a novel drug candidate for the treatment of Parkinson's disease. Additionally, he has developed a quinazoline derivative, which boasts improved anti-tumor activity, further emphasizing his contributions to pharmacology.

Career Highlights

During his professional journey, Wenteng Chen has worked with notable organizations, including Shanghai Pharmaceuticals Holdings Co., Ltd. and Zhejiang University. His tenure at these institutions has enabled him to collaborate with leading experts in the field and advance his research efforts, solidifying his reputation as an innovator in pharmaceutical sciences.

Collaborations

Chen has worked alongside talented coworkers, such as Yongping Yu and Guangxin Xia. Their collaboration has undoubtedly fueled Chen’s research endeavors, allowing for the exchange of ideas and techniques, which is essential in the dynamic field of innovation and invention.

Conclusion

Wenteng Chen is an exemplary figure in the realm of pharmaceutical inventions. His innovative patents highlight the potential for new treatments in addressing critical health issues, such as Parkinson's disease and cancer. Through his work and collaborations, he continues to contribute to the advancement of medicine and exemplifies the spirit of innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…